Korean competitors challenge Pfizer's leadership in amlodipine

Korea's major pharmaceutical firms are racing to increase their market share in the domestic amlodipine market, prompting speculation that Pfizer Korea, a Korean unit of a multinational pharmaceutical firm, may face an uphill battle in the years ahead.

Another factor is that local large hospitals have been increasingly in favor of locally produced first generics. In fact, Several Hospital sa...